Vimarsana
Biggest News Aggregation in the World

Page 7 - Edison Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edison Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edison Group Today - Breaking & Trending Today

Electric cars won't be green until we sort out the grid - Vimarsana News

Electric cars won't be green until we sort out the grid

JEFF Rogers (Letters, February 26) chides DB Watson (Letters, February 21) for writing that electric vehicles are not “emission-free”. He…

Questions linger on jobs as Rolls-Royce profits surge - Vimarsana News

Questions linger on jobs as Rolls-Royce profits surge

Consultations on up to 2,500 jobs cuts at Rolls-Royce are continuing following an "exceptional" financial performance by the company in…

Hargreaves Lansdown profits drop 8% as platform ramps up technology spend - Vimarsana News

Hargreaves Lansdown profits drop 8% as platform ramps up technology spend

Hargreaves Lansdown profits fell in H2 2023 due to higher spend on technology and staff costs, as inflows slowed due to lower investor confidence.

How to cure the City's depression? Some retail investor therapy - Vimarsana News

How to cure the City's depression? Some retail investor therapy

The London Stock Exchange needs wide reform, but recentering the role of retail investors could be a shot in the arm, writes Fraser Thorne.

Source: cityam.com
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation - Vimarsana News

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

MELBOURNE, Australia and NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased to announce the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-N for tobacco smoking cessation and control of relapse. The pre-IND teleconference included representatives f

Source: yahoo.com